The University of Iowa

State Hygienic Laboratory

Breadcrumb

  1. Home
  2. Testing Specialties
  3. Diagnostic and Clinical Testing

Test Detail


Syphilis VDRL (CSF)

Back to Test Directory
Test Description
  • Contact: Serology (319) 335-4291
  • Test Request Form: Serology/Immunology
  • SHL OpenELIS Code: 768
Initial screening test for syphilis for Cerebrospinal Fluid (CSF) samples. Titer given only when Syphilis VDRL test is positive.
Performed Avg. Turnaround Time Method
Coralville, 8 a.m. - 5 p.m., M - F
3 - 5 business days Flocculation
Fee CPT Code(s)
$8.68 86592
Specimen Requirements
Specimen Type: Minimum 0.5 mL Cerebrospinal Fluid (CSF)
Collection Instructions: Aseptically collect CSF from patient into a sterile, clear plastic tube with screw-top lid. Centrifuge if there is visible cellular debris.
Shipping:
Specimens should be stored and shipped under the same conditions. Wrap specimen container in absorbent material and place inside a biohazard bag. Transport specimen with cold pack. Ship to the Coralville location.
Temperature and Stability: Refrigerate (2-8 degrees C); stable for less than 5 days. Freeze (-20 degrees C); stable for more than 5 days.
Rejection Criteria: Specimens will be rejected if received under these conditions:

Plasma. Serum. Contaminated, hemolyzed, or severely lipemic specimens. Specimens not received in the correct temperature ranges stated under "Temperature and Stability" will be rejected.
Expected Results:
Non Reactive, Weakly Reactive, Reactive with titer
Comments
VDRL is the preferred test for cerebrospinal fluid. Acceptable initial screening test for syphilis, as well as for monitoring treatment response in established syphilis. If VDRL is reactive, then a titer will be added.
Alternate Names
Syphilis CSF, VDRL Reflex to titer
The University of Iowa

State Hygienic Laboratory

General inquires
SHL Client Services
319-335-4500 or 1-800-421-IOWA (4692)
ask-shl@uiowa.edu

Footer primary

  • HIPAA Notice of Privacy Practice
  • Copyright 2025 The University of Iowa
  • Privacy Notice
  • UI Nondiscrimination Statement
  • Accessibility